Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
38.5M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
7.11M
-
Shares change
-
-1.42M
-
Total reported value, excl. options
-
$69.3M
-
Value change
-
-$22.9M
-
Number of buys
-
17
-
Number of sells
-
-36
-
Price
-
$9.74
Significant Holders of Protara Therapeutics, Inc. - Common Stock (TARA) as of Q2 2021
59 filings reported holding TARA - Protara Therapeutics, Inc. - Common Stock as of Q2 2021.
Protara Therapeutics, Inc. - Common Stock (TARA) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.11M shares
of 38.5M outstanding shares and own 18.49% of the company stock.
Largest 10 shareholders include Opaleye Management Inc. (2.56M shares), Rock Springs Capital Management LP (694K shares), Ikarian Capital, LLC (585K shares), ORBIMED ADVISORS LLC (450K shares), VANGUARD GROUP INC (437K shares), PERCEPTIVE ADVISORS LLC (422K shares), FRANKLIN RESOURCES INC (350K shares), CITADEL ADVISORS LLC (342K shares), BOXER CAPITAL, LLC (209K shares), and BAKER BROS. ADVISORS LP (200K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.